本頁面由Tiger Trade Technology Pte. Ltd.提供服務

萬春藥業

0.7498
+0.04105.78%
盤後0.74980.00000.00%18:48 EDT
成交量:4.53萬
成交額:3.39萬
市值:3,083.35萬
市盈率:-4.58
高:0.7597
開:0.7132
低:0.7132
收:0.7088
52周最高:2.44
52周最低:0.5657
股本:4,112.23萬
流通股本:3,195.01萬
量比:1.04
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):-0.1638
每股收益(LYR):-0.0249
淨資產收益率:-310.48%
總資產收益率:-22.86%
市淨率:-0.87
市盈率(LYR):-30.12

資料載入中...

2025/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/04/11

重要事件披露

Form 8-K - Current report
2025/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/10

SEC問詢函

Form CORRESP - Correspondence
2024/07/02

SEC問詢函

Form CORRESP - Correspondence
2024/04/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/15

SEC問詢函

Form CORRESP - Correspondence
2023/04/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals